EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹9,473 Cr | ₹8,122 Cr | ₹7,709 Cr | ₹6,573 Cr | ₹5,947 Cr |
What is the latest Total Liabilities ratio of EMCURE PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹9,473 Cr |
| Mar2025 | ₹8,122 Cr |
| Mar2024 | ₹7,709 Cr |
| Mar2023 | ₹6,573 Cr |
| Mar2022 | ₹5,947 Cr |
How is Total Liabilities of EMCURE PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹9,473 Cr | 16.64 | |
| Mar2025 | ₹8,122 Cr | 5.35 | |
| Mar2024 | ₹7,709 Cr | 17.28 | |
| Mar2023 | ₹6,573 Cr | 10.53 | |
| Mar2022 | ₹5,947 Cr | - | |
Compare Total Liabilities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹36,531.5 Cr | -2.5% | 2.5% | 47.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -2.5% |
2.5% |
47.4% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses